BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2227249)

  • 21. Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and in inflammatory bowel disease.
    Hirata I; Berrebi G; Austin LL; Keren DF; Dobbins WO
    Dig Dis Sci; 1986 Jun; 31(6):593-603. PubMed ID: 2423309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of major histocompatibility complex class II antigens on human keratinocytes.
    Niedecken H; Lutz G; Bauer R; Kreysel HW
    J Am Acad Dermatol; 1988 Dec; 19(6):1030-7. PubMed ID: 2462575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DR antigen expression in macroscopically uninvolved areas of intestinal epithelia in Crohn's disease.
    Chiba M; Iizuka M; Horie Y; Igarashi K; Masamune O
    Gastroenterol Jpn; 1989 Aug; 24(4):365-72. PubMed ID: 2673907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers.
    Fais S; Pallone F; Squarcia O; Biancone L; Ricci F; Paoluzi P; Boirivant M
    Clin Exp Immunol; 1987 Jun; 68(3):605-12. PubMed ID: 3308219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.
    Demetter P; De Vos M; Van Huysse JA; Baeten D; Ferdinande L; Peeters H; Mielants H; Veys EM; De Keyser F; Cuvelier CA
    Ann Rheum Dis; 2005 Feb; 64(2):321-4. PubMed ID: 15166002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.
    Momburg F; Herrmann B; Moldenhauer G; Möller P
    Int J Cancer; 1987 Nov; 40(5):598-603. PubMed ID: 3316049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of HPLC profiles of human class II MHC-bound peptides isolated from intestine with inflammatory bowel disease.
    Oshitani N; Hato F; Jinno Y; Sawa Y; Hara J; Nakamura S; Matsumoto T; Arakawa T; Kitano A; Kitagawa S; Kuroki T
    Dig Dis Sci; 2002 Sep; 47(9):2088-94. PubMed ID: 12353860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of HLA-D/Ii antigen expression in breast carcinoma with local lymphohistiocytic infiltration reveals considerable dysregulation in a subset of tumors.
    Koretz K; Moldenhauer G; Majdic O; Möller P
    Int J Cancer; 1989 Nov; 44(5):816-22. PubMed ID: 2583862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution and differential expression of MHC class II antigens (HLA-DR, DP, and DQ) in human fetal adrenal, pancreas, thyroid, and gut.
    Oliver AM; Sewell HF; Abramovich DR; Thomson AW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):651-2. PubMed ID: 2495628
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduction in HLA-DR, HLA-DQ and HLA-DP expression by Leu-M3+ cells from the peripheral blood of patients with thermal injury.
    Gibbons RA; Martinez OM; Lim RC; Horn JK; Garovoy MR
    Clin Exp Immunol; 1989 Mar; 75(3):371-5. PubMed ID: 2495202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus.
    Farthing PM; Cruchley AT
    J Oral Pathol Med; 1989 May; 18(5):305-9. PubMed ID: 2475620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major histocompatibility complex (MHC) class II antigen (HLA-DR, DQ, and DP) expression in human fetal endocrine organs and gut.
    Oliver AM; Thomson AW; Sewell HF; Abramovich DR
    Scand J Immunol; 1988 Jun; 27(6):731-7. PubMed ID: 3293192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis.
    Stokkers PC; Reitsma PH; Tytgat GN; van Deventer SJ
    Gut; 1999 Sep; 45(3):395-401. PubMed ID: 10446108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma.
    Qin OY; el-Youssef M; Yen-Lieberman B; Sapatnekar W; Youngman KR; Kusugami K; Fiocchi C
    Dig Dis Sci; 1988 Dec; 33(12):1528-36. PubMed ID: 3143537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.
    Liversidge JM; Sewell HF; Forrester JV
    Clin Exp Immunol; 1988 Sep; 73(3):489-94. PubMed ID: 3145163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunocytochemical characterization of the DNA-polymerase alpha-positive colonic mucosal epithelial cells in patients with ulcerative colitis].
    Matsumoto T; Kitano A; Nakamura S; Oshitani N; Obata A; Hashimura H; Hiki M; Okawa K; Nagura H; Kobayashi K
    Nihon Shokakibyo Gakkai Zasshi; 1989 Aug; 86(8):1611-6. PubMed ID: 2585787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in immunophenotyping of mucosal lymphocytes between ulcerative colitis and Crohn's disease.
    Lee HB; Kim JH; Yim CY; Kim DG; Ahn DS
    Korean J Intern Med; 1997 Jan; 12(1):7-15. PubMed ID: 9159031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA class II expression in normal and inflamed conjunctiva.
    Lee SJ; Rice BA; Foster CS
    Reg Immunol; 1990-1991; 3(4):177-85. PubMed ID: 2129602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.